SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001640455-21-000078
Filing Date
2021-04-26
Accepted
2021-04-26 16:41:15
Documents
5
Period of Report
2021-06-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A jnce042621def14a.htm DEF 14A 440025
2 jnce_2021xproxycardx11a.jpg GRAPHIC 217809
3 jnce_2021xproxycardx21a.jpg GRAPHIC 193816
4 jouncelogo1a.jpg GRAPHIC 66963
5 rmsignature1a.jpg GRAPHIC 2641
  Complete submission text file 0001640455-21-000078.txt   1104264
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37998 | Film No.: 21854422
SIC: 2836 Biological Products, (No Diagnostic Substances)